| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
19 companies
Cormorant Asset Management, LP is a Former 10% Owner at EyePoint, Inc. with holdings across 19 companies. Recent SEC Form 4 filings include 48 buys and 13 sells.
Estimated insider holdings value: $639.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | EYPT Eyepoint, Inc. | - | Buy | 581,765 | $18.03 | $10,489,446.18 | +4.1% | -44.7% | -67.6% | |
| Apr 1, 2024 | IMRX Immuneering Corp | - | Sell | 400,000 | $2.90 | $1,160,181.00 | -1.5% | -57.5% | -45.5% | |
| Mar 15, 2024 | IMRX Immuneering Corp | - | Sell | 909,091 | $3.02 | $2,749,003.29 | -4.7% | -11.5% | -16.2% | |
| Mar 8, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | - | Buy | 550,000 | $42.41 | $23,327,559.60 | +3.2% | +3.7% | -84.9% | |
| Feb 2, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | - | Buy | 750,000 | $19.00 | $14,250,000.00 | +103.4% | +43.0% | -63.4% | |
| Jan 26, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | - | Buy | 282,632 | $32.24 | $9,111,940.74 | +3.5% | +13.6% | -64.3% | |
| Jan 11, 2024 | EYPT Eyepoint, Inc. | - | Buy | 855,000 | $19.94 | $17,051,100.00 | +7.0% | +6.6% | -59.0% | |
| Dec 8, 2023 | EYPT Eyepoint, Inc. | - | Buy | 588,235 | $17.00 | $9,999,995.00 | +10.8% | +32.2% | -54.5% | |
| Dec 4, 2023 | EYPT Eyepoint, Inc. | - | Buy | 1,919,057 | $21.82 | $41,874,150.55 | +2.3% | +41.3% | -54.4% | |
| Oct 25, 2021 | VTYX Ventyx Biosciences, Inc. | Former 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +79.6% | -21.0% | +50.6% |